We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Major shareholders page has been updated with new placing shares.
https://www.provexis.com/shareholder-information/major-shareholders/
Team DSM
FF gets a small mention
“We are looking for new technology and improved details in both nutrition and materials to make a difference. To give an example; in a grand tour, recovery is essential to get the best possible performance. Nutrition plays a crucial role in this. DSM has devised all kinds of ways to recover faster through nutrition and to tire less quickly. For example, by cutting proteins with the product PeptoPro, or by reducing the stress on your blood vessels via the product Fruitflow. In addition, we will continue to develop Personalized Nutrition togetherspecifically tailored to the needs of the riders. Based on all kinds of factors such as your effort, the amount of sleep or your fitness, it is determined what exactly you need in terms of nutrition. Your nutrition is therefore tailored to your life pattern. "
https://www.sportnext.nl/sponsoring/team-dsm-koppelt-topsport-aan-duurzaamheid-en-innovatie/
Think its just a mess up by LSE chat.
On the day of the Director / PDMR notification that page was showing all 6,666,667 against Buck when he only took 1,666,667.
Director buys need to notified to the market almost immediately and the annual report shows Buck as having 25,416,667
It does look like he’s bought 5m over the two recent placing , which is a much more positive signal shhhh
This doesn’t add up either , Dawson Buck is shown as holding 25, million shares before the latest placing ,then after buying 1,666667 shares in the placing , now shown as holding 30 m. , a Math not great but even I can see that doesn’t add up , did he buy more in the first placing and it hasn’t shown up yet ! https://www.lse.co.uk/DirectorsDeals.asp?shareprice=PXS&share=Provexis
Yes Spangdog's "order 162439 feb 29th" does seem strange. You might need to read it more carefully, especially the date.
Maybe China kicking in
Look back at Spangdog Sat 19:27 seems strange.
Yes that is what it says on the order !! I know no other reason.
.. But the next few days might have very low figures. I guess it just depends on which day of the month the initial order was placed. I don't know if it's relevant at all but mine came by DPD this time, whereas all previous ones were delivered by Royal Mail.
Eyeore is that correct if so that’s a increase of 726 in one day !
Ono: 162930 24/02
23/02/21 162204.
Going off my subscription order numbers, the recent monthly increases have been, Nov 2720, Dec 2856, Jan 3031, Feb 3254.
I assumed the £8,346 for "Fruitflow+ nitrates - in development" was part payment of the £55k due to us from By-Health for the project work on Fruitflow+ nitrates.
"Projects conducted under the agreement will be focussed on specific areas of commercial focus for By-Health,
and the first project which has been agreed will concentrate on the use of Fruitflow with nitrates in exercise,
an area of considerable commercial interest to By-Health in China. Project work will be managed and
conducted by Provexis primarily in the UK, led by Provexis’ Chief Scientific Officer Dr Niamh O’Kennedy and
supported by outsourced research partners which will be appointed and managed by Provexis.
The Fruitflow with nitrates in exercise project will require the use of healthy volunteers and it has therefore
been delayed by the COVID-19 pandemic. It is expected that the project will be re-started when it is safe to do
so, and as the project progresses it is expected to provide gross income to Provexis in excess of £55k, to
include an element of overhead recovery. The project will not affect the ownership of Provexis’ existing,
substantial intellectual property for the Fruitflow with nitrates formulation, which has potential patent protection
out to December 2033."
Not sure why the App has been delayed for so long but assume it should have been out in 2019 as its shown in these videos.
https://youtu.be/hhPBlnnCr2M?t=131
https://youtu.be/3Ih0wsIcTEE?t=99
Kievsky
looking forward to it...
They also said:
A Fruitflow App is also being developed, primarily for use on mobile device platforms.
What's all that about, presumably for the younger/Chinese market ?
WS
Ye said exactly. Did I see in the RNS about income received from France+ nitrates. Looking forward to our meeting for a pint in July. Hopefully by then things will become more clearer. As I say there are clues/pointers in the RNS, S
Kievsky
exactly, IF chooses his words very carefully and to feed us a crumb about brand owners is significant IMHO - the link with SiS Rego recovery was dropped for a reason and with the US patent now in place we might see progress here sooner rather than later (about time).
W-ever optimistic-$
From interims RNS
The Company continues to work on a potential Fruitflow+ nitrates product which would be supported by the Company's strong patent position in this area, with the involvement now of third party manufacturers and with some interest already generated from brand owners. The product will have anti-inflammatory and circulation benefits for athletes seeking to recover after exercise, properties which would also be potentially beneficial to a wide range of other consumers to include people who are less active and people who suffering from the symptoms of basic ageing.
COVID-19
The Company and DSM have experienced increased consumer interest for Fruitflow in recent months, in light of the COVID-19 pandemic, as consumers look to nutritional interventions to help them fortify the circulatory system against the effects of COVID-19. The Company and DSM will look to maximise the commercial opportunities arising from this increased consumer interest in Fruitflow, and will further promote the core blood circulatory and anti-inflammatory benefits of the product.
In September 2020 Fruitflow was recognised in a review article by the Frontiers in Nutrition journal www.frontiersin.org/articles/10.3389/fnut.2020.583080/full which stated that nutraceuticals such as Fruitflow may serve as:
'A safe antiplatelet prophylactic treatment for those at high risk of COVID-19 who may also be at increased risk of thrombotic complications and an alternative to pharmacological compounds that may cause greater risk of bleeding.'
Think he means this.
COVID-19
The Company and DSM have experienced increased consumer interest for Fruitflow in recent months, in light of the COVID-19 pandemic, as consumers look to nutritional interventions to help them fortify the circulatory system against the effects of COVID-19. The Company and DSM will look to maximise the commercial opportunities arising from this increased consumer interest in Fruitflow, and will further promote the core blood circulatory and anti-inflammatory benefits of the product.
In September 2020 Fruitflow was recognised in a review article by the Frontiers in Nutrition journal www.frontiersin.org/articles/10.3389/fnut.2020.583080/full which stated that nutraceuticals such as Fruitflow may serve as:
'A safe antiplatelet prophylactic treatment for those at high risk of COVID-19 who may also be at increased risk of thrombotic complications and an alternative to pharmacological compounds that may cause greater risk of bleeding.'
--------------------------------------------------
Who knows? as an ex AVCT holder I do not think CV19 is a deal maker , this stance is the result of disappointment . AVCT had a great fast accurate test a year ago and the Gov didn't bother with it , only now the horse has bolted might they take it up! pathetic and conspiracy theory inducing IMO. FF is very different of course ,if the Chinese think they will make money then it will happen.
Assuming that you mean the RNS of the 19th then I am struggling to find what you are referring to kievsky.
check last RNS near bottom of page note 2
I expect to see some progress on sport recovery
W$
I'd expect to see an update regarding expanding the reach of Fruitflow+Omega3 long before that. They didn't raise such an increased funding just to sit on it long term. Could be USA I reckon.
They used to say it was Heart Health month, but don’t seem to bother with that anymore. No other relevance that I’m aware of. Next update may be September if anything like last year.